Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aparna Hegde

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
International Urogynecology Journal|May 1, 2019
FPMRS challenges on behalf of the Collaborative Research in Pelvic Surgery Consortium (CoRPS): managing complicated cases : Series 3: Challenging recurrent prolapse in a medically complicated patientDanielle D Antosh, Ladin A Yurteri-Kaplan, David Shveiky, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 7, 2017
Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockadeChipman Rg Stroud, Aparna Hegde, Cynthia Cherry, et al.
JMIR Research Protocols|December 9, 2025
Impact of a Multicomponent Intervention to Build Capacity of Public Health Workers to Make Algorithmic Diagnosis and Management of High-Risk Pregnancies in Uttar Pradesh, India: Protocol for a Matched-Control, Before-After, Quasi-Experimental Study With a Mixed Methods DesignHanimi Reddy Modugu, Chetan Purad, Venkatesh Irugulapati, et al.
Plos One|September 10, 2019
Effect of calcium glucoheptonate on proliferation and osteogenesis of osteoblast-like cells in vitroPrashant Kumar Modi, Ashwini Prabhu, Yashodhar P Bhandary, et al.
International Urogynecology Journal|January 3, 2022
International urogynecology consultation chapter 1 committee 2: Epidemiology of pelvic organ prolapse: prevalence, incidence, natural history, and service needsHeidi W Brown, Aparna Hegde, Markus Huebner, et al.
Acta Oncologica (Stockholm, Sweden)|December 16, 2017
Co-relation of overall survival with peripheral blood-based inflammatory biomarkers in advanced stage non-small cell lung cancer treated with anti-programmed cell death-1 therapy: results from a single institutional databaseAbdul Rafeh Naqash, Chipman Robert Geoffrey Stroud, Muhammad Umer Butt, et al.
Cancer Immunology Research|November 4, 2025
RAS(ON) Multiselective Inhibition Drives Antitumor Immunity in Preclinical Models of NRAS-Mutant MelanomaLarissa Anastacio Da Costa Carvalho, Nataliya Tovbis Shifrin, Manali S Phadke, et al.
The New England Journal of Medicine|May 6, 2026
Daraxonrasib in Previously Treated Advanced <i>RAS</i>-Mutated Pancreatic CancerBrian M Wolpin, Wungki Park, Ignacio Garrido-Laguna, et al.
Nature Reviews. Clinical Oncology|March 16, 2021
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trialsAakash Desai, Justin F Gainor, Aparna Hegde, et al.
Nature Reviews. Clinical Oncology|March 24, 2021
Author Correction: COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trialsAakash Desai, Justin F Gainor, Aparna Hegde, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
International Urogynecology Journal|May 1, 2019
FPMRS challenges on behalf of the Collaborative Research in Pelvic Surgery Consortium (CoRPS): managing complicated cases : Series 3: Challenging recurrent prolapse in a medically complicated patientDanielle D Antosh, Ladin A Yurteri-Kaplan, David Shveiky, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 7, 2017
Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockadeChipman Rg Stroud, Aparna Hegde, Cynthia Cherry, et al.
JMIR Research Protocols|December 9, 2025
Impact of a Multicomponent Intervention to Build Capacity of Public Health Workers to Make Algorithmic Diagnosis and Management of High-Risk Pregnancies in Uttar Pradesh, India: Protocol for a Matched-Control, Before-After, Quasi-Experimental Study With a Mixed Methods DesignHanimi Reddy Modugu, Chetan Purad, Venkatesh Irugulapati, et al.
Plos One|September 10, 2019
Effect of calcium glucoheptonate on proliferation and osteogenesis of osteoblast-like cells in vitroPrashant Kumar Modi, Ashwini Prabhu, Yashodhar P Bhandary, et al.
International Urogynecology Journal|January 3, 2022
International urogynecology consultation chapter 1 committee 2: Epidemiology of pelvic organ prolapse: prevalence, incidence, natural history, and service needsHeidi W Brown, Aparna Hegde, Markus Huebner, et al.
Acta Oncologica (Stockholm, Sweden)|December 16, 2017
Co-relation of overall survival with peripheral blood-based inflammatory biomarkers in advanced stage non-small cell lung cancer treated with anti-programmed cell death-1 therapy: results from a single institutional databaseAbdul Rafeh Naqash, Chipman Robert Geoffrey Stroud, Muhammad Umer Butt, et al.
Cancer Immunology Research|November 4, 2025
RAS(ON) Multiselective Inhibition Drives Antitumor Immunity in Preclinical Models of NRAS-Mutant MelanomaLarissa Anastacio Da Costa Carvalho, Nataliya Tovbis Shifrin, Manali S Phadke, et al.
The New England Journal of Medicine|May 6, 2026
Daraxonrasib in Previously Treated Advanced <i>RAS</i>-Mutated Pancreatic CancerBrian M Wolpin, Wungki Park, Ignacio Garrido-Laguna, et al.
Nature Reviews. Clinical Oncology|March 16, 2021
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trialsAakash Desai, Justin F Gainor, Aparna Hegde, et al.
Nature Reviews. Clinical Oncology|March 24, 2021
Author Correction: COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trialsAakash Desai, Justin F Gainor, Aparna Hegde, et al.
Pageof 7